LC-MS/MS in endocrinology: What is the profit of the last 5 years?

Bioanalysis

Volumn 6, Issue 1, 2014, Pages 43-57

  Ackermans, Mariëtte Theodora ^a   Endert, Erik ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVED HORMONE; HORMONE; PEPTIDE HORMONE; STEROID HORMONE; UNCLASSIFIED DRUG;

CLINICAL LABORATORY; CROSS REACTION; DIAGNOSTIC TEST; ENDOCRINOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROFIT; REFERENCE VALUE; REVIEW; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

BIOGENIC AMINES; CHROMATOGRAPHY, LIQUID; ENDOCRINOLOGY; HAIR; HUMANS; LIMIT OF DETECTION; PARATHYROID HORMONE; SALIVA; STEROIDS; TANDEM MASS SPECTROMETRY; THYROTROPIN; VALIDATION STUDIES AS TOPIC; VITAMIN D;

EID: 84890939752     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.13.300     Document Type: Review

References (156)

1. Lepage R, Albert C. Fifty years of development in the endocriology laboratory. Clin. Biochem. 39(5), 542-557 (2006).
2. Wild D. The immunoassay handbook (3rd Edition). Elsevier, The Netherlands (2013).
3. Carvalho VM. The coming of age of liquid chromatography coupled to tandem mass spectrometry in the endocrinology laboratory. J. Chromatogr. B Analyt. Technol. Biomed.Life Sci. 883-884, 50-58 (2012).
4. Rauh M. LC-MS/MS for protein and peptide quantification in clinical chemistry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 883-884, 59-67 (2012).
5. van den Ouweland JM, Kema IP. The role of liquid chromatography-tandem mass spectrometry in the clinical laboratory. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 883-884, 18-32 (2012).
6. Wu AH, French D. Implementation of liquid chromatography/mass spectrometry into the clinical laboratory. Clin. Chim. Acta 420, 4-10 (2013).
7. US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research. Guidance for Industry, Bioanalytical Method Validation. US FDA, MD, USA (2001).
8. Bui HN, Sluss PM, Blincko S, Knol DL, Blankenstein MA, Heijboer AC. Dynamics of serum testosterone during the menstrual cycle evaluated by daily measurements with an ID-LC-MS/MS method and a 2nd generation automated immunoassay. Steroids 78(1), 96-101 (2013).
9. Heijboer AC, Blankenstein MA, Kema IP, Buijs MM. Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. Clin. Chem. 58(3), 543-548 (2012).
10. Buttler RM, Kruit A, Blankenstein MA, Heijboer AC. Measurement of dehydroepiandrosterone sulphate (DHEAS): a comparison of isotope-dilution liquid chromatography tandem mass spectrometry (ID-LC-MS/MS) and seven currently available immunoassays. Clin. Chim. Acta 424C, 22-26 (2013).
11. Moon HW, Cho JH, Hur M et al. Comparison of four current 25-hydroxyvitamin D assays. Clin. Biochem. 45(4-5), 326-330 (2012).
12. Kelley JM, Melanson SE, Snyder ML, Cremers S, Jarolim P. Method comparison of a 25-hydroxy vitamin D enzyme immunoassay to liquid chromatography tandem mass spectroscopy. Clin. Chem. Lab. Med. 50(6), 1137-1138 (2012).
13. Ong L, Saw S, Sahabdeen NB, Tey KT, Ho CS, Sethi SK. Current 25-hydroxyvitamin D assays: do they pass the test? Clin. Chim. Acta 413(13-14), 1127-1134 (2012).
14. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 75(13), 3019-3030 (2003).
15. Taylor PJ. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin. Biochem. 38(4), 328-334 (2005).
16. Davison AS, Milan AM, Dutton JJ. Potential problems with using deuterated internal standards for liquid chromatography-tandem mass spectrometry. Ann. Clin. Biochem. 50(Pt 3), 274 (2013).
17. Owen LJ, Keevil BG. Testosterone measurement by liquid chromatography tandem mass spectrometry: the importance of internal standard choice. Ann. Clin. Biochem. 49(Pt 6), 600-602 (2012).
18. Bui HN, Blankenstein MA, Heijboer AC. Isotopically labelled testosterone derivatives as internal standards in liquid chromatography-tandem mass spectrometry. Ann. Clin. Biochem. 50(Pt 3), 275-276 (2013).
19. Duxbury K, Owen L, Gillingwater S, Keevil B. Naturally occurring isotopes of an analyte can interfere with doubly deuterated internal standard measurement. Ann. Clin. Biochem. 45(Pt 2), 210-212 (2008).
20. Shindo N, Yamauchi N, Murayama K, Fairbrother A, Korlik S. Identification of 17-hydroxyprogesterone and other steroid hormones in saliva from a normal child and patients with congenital adrenal hyperplasia by plasmaspray liquid chromatography/mass spectrometry. Biomed. Chromatogr. 4(4), 171-174 (1990).
21. Taylor RL, Machacek D, Singh RJ. Validation of a high-throughput liquid chromatography-tandem mass spectrometry method for urinary cortisol and cortisone. Clin. Chem. 48(9), 1511-1519 (2002).
22. Kushnir MM, Rockwood AL, Roberts WL, Yue B, Bergquist J, Meikle AW. Liquid chromatography tandem mass spectrometry for analysis of steroids in clinical laboratories. Clin. Biochem. 44(1), 77-88 (2011).
23. Kulle AE, Welzel M, Holterhus PM, Riepe FG. Principles and clinical applications of liquid chromatography-tandem mass spectrometry for the determination of adrenal and gonadal steroid hormones. J. Endocrinol. Invest. 34(9), 702-708 (2011).
24. Inder WJ, Dimeski G, Russell A. Measurement of salivary cortisol in 2012-Laboratory techniques and clinical indications. Clin. Endocrinol. (Oxf) 77(5), 645-651 (2012).
25. Higashi T. Salivary hormone measurement using LC-MS/MS: specific and patient-friendly tool for assessment of endocrine function. Biol. Pharm. Bull. 35(9), 1401-1408 (2012).
26. de Bos Kuil MJ, Endert E, Fliers E, Prummel MF, Romijn JA, Wiersinga WM. Establishment of reference values for endocrine tests. I: Cushing's syndrome. Neth. J. Med. 53(4), 153-163 (1998).
27. Findling JW, Raff H. Cushing's Syndrome: important issues in diagnosis and management. J. Clin. Endocrinol. Metab. 91(10), 3746-3753 (2006).
28. Holleman F, Endert E, Prummel MF, van Vessem-Timmermans M, Wiersinga WM, Fliers E. Evaluation of endocrine tests. B: screening for hypercortisolism. Neth. J. Med. 63(9), 348-353 (2005).
29. Ten S, New M, Maclaren N. Clinical review 130: Addison's disease 2001. J. Clin. Endocrinol. Metab. 86(7), 2909-2922 (2001).
30. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J. Clin. Endocrinol. Metab. 94(8), 2692-2701 (2009).
31. de Kloet CS, Vermetten E, Geuze E, Kavelaars A, Heijnen CJ, Westenberg HG. Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review. J. Psychiatr. Res. 40(6), 550-567 (2006).
32. Heim CM and Nater UM. Hypocortisolism and stress. Encyclopedia of Stress (2nd edition), Elsevier, The Netherlands 400-407 (2007).
33. Vogelzangs N, Beekman AT, Milaneschi Y, Bandinelli S, Ferrucci L, Penninx BW. Urinary cortisol and six-year risk of all-cause and cardiovascular mortality. J. Clin. Endocrinol. Metab. 95(11), 4959-4964 (2010).
34. Schleimer RP. Interactions between the hypothalamic-pituitary-adrenal axis and allergic inflammation. J. Allergy Clin. Immunol. 106(5 Suppl.), S270-S274 (2000).
35. Greenspan FS, Gardner DG. Basic and clinical endocrinology (7th Edition). Lange medical books/McGraw-Hill, NY, USA (2004).
36. Chen Z, Li J, Zhang J et al. Simultaneous determination of hair cortisol, cortisone and DHEAS with liquid chromatography-electrospray ionization-tandem mass spectrometry in negative mode. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 929, 187-194 (2013).
37. Zhang J, Li J, Xu Y, Yang J, Chen Z, Deng H. Characteristics of novel hair-based biomarker for the activity assessment of 11beta-hydroxysteroid dehydrogenase. Clin. Chim. Acta doi:10.1016/j.cca.2013.08.022 (2013).
38. Krumbholz A, Anielski P, Reisch N, Schelling GP, Thieme D. Diagnostic value of concentration profiles of glucocorticosteroids and endocannabinoids in hair. Ther. Drug Monit. 35(5), 600-607 (2013).
39. Steudte S, Kirschbaum C, Gao W et al. Hair cortisol as a biomarker of traumatization in healthy individuals and posttraumatic stress disorder patients. Biol. Psychiatry 74(9), 639-646 (2013).
40. Ben KM, Tegethoff M, Meinlschmidt G, Jamey C, Ludes B, Raul JS. Simultaneous measurement of endogenous cortisol, cortisone, dehydroepiandrosterone, and dehydroepiandrosterone sulfate in nails by use of UPLC-MS-MS. Anal. Bioanal. Chem. 401(4), 1153-1162 (2011).
41. Gosetti F, Mazzucco E, Gennaro MC, Marengo E. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 927, 22-36 (2013).
42. Kushnir MM, Rockwood AL, Bergquist J et al. High-sensitivity tandem mass spectrometry assay for serum estrone and estradiol. Am. J. Clin. Pathol. 129(4), 530-539 (2008).
43. Kushnir MM, Blamires T, Rockwood AL et al. Liquid chromatography-tandem mass spectrometry assay for androstenedione, dehydroepiandrosterone, and testosterone with pediatric and adult reference intervals. Clin. Chem. 56(7), 1138-1147 (2010).
44. Minutti CZ, Lacey JM, Magera MJ et al. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 89(8), 3687-3693 (2004).
45. Reisch N, Idkowiak J, Hughes BA et al. Prenatal diagnosis of congenital adrenal hyperplasia caused by P450 oxidoreductase deficiency. J. Clin. Endocrinol. Metab. 98(3), E528-E536 (2013).
46. Rauh M. Steroid measurement with LC-MS/MS in pediatric endocrinology. Mol. Cell. Endocrinol. 301(1-2), 272-281 (2009).
47. Guo T, Taylor RL, Singh RJ, Soldin SJ. Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry. Clin. Chim. Acta 372(1-2), 76-82 (2006).
48. Rossi C, Calton L, Brown HA et al. Confirmation of congenital adrenal hyperplasia by adrenal steroid profiling of filter paper dried blood samples using ultra-performance liquid chromatography-tandem mass spectrometry. Clin. Chem. Lab. Med. 49(4), 677-684 (2011).
49. Roth HJ, Schmidt-Gayk H, Weber H, Niederau C. Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Ann. Clin. Biochem. 45(Pt 2), 153-159 (2008).
50. Gathungu RM, Flarakos CC, Reddy GS, Vouros P. The role of mass spectrometry in the analysis of vitamin D compounds. Mass Spectrom. Rev. 32(1), 72-86 (2013).
51. El-Khoury JM, Reineks EZ, Wang S. Progress of liquid chromatography-mass spectrometry in measurement of vitamin D metabolites and analogues. Clin. Biochem. 44(1), 66-76 (2011).
52. Vogeser M. Quantification of circulating 25-hydroxyvitamin D by liquid chromatography-tandem mass spectrometry. J. Steroid Biochem. Mol. Biol. 121(3-5), 565-573 (2010).
53. Glade MJ. Vitamin D: health panacea or false prophet? Nutrition 29(1), 37-41 (2013).
54. Carrozza C, Persichilli S, Canu G et al. Measurement of 25-hydroxyvitamin vitamin D by liquid chromatography tandem-mass spectrometry with comparison to automated immunoassays. Clin. Chem. Lab. Med. 50(11), 2033-2035 (2012).
55. Farrell CJ, Martin S, McWhinney B, Straub I, Williams P, Herrmann M. State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin. Chem. 58(3), 531-542 (2012).
56. Herrmann M, Harwood T, Gaston-Parry O et al. A new quantitative LC tandem mass spectrometry assay for serum 25-hydroxy vitamin D. Steroids 75(13-14), 1106-1112 (2010).
57. van den Ouweland JM, Vogeser M, Bacher S. Vitamin D and metabolites measurement by tandem mass spectrometry. Rev. Endocr. Metab. Disord. 14(2), 159-184 (2013).
58. Chen H, McCoy LF, Schleicher RL, Pfeiffer CM. Measurement of 25-hydroxyvitamin D3 (25OHD3) and 25-hydroxyvitamin D2 (25OHD2) in human serum using liquid chromatography-tandem mass spectrometry and its comparison to a radioimmunoassay method. Clin. Chim. Acta 391(1-2), 6-12 (2008).
59. Kushnir MM, Ray JA, Rockwood AL et al. Rapid analysis of 25-hydroxyvitamin D(2) and D(3) by liquid chromatography-tandem mass spectrometry and association of vitamin D and parathyroid hormone concentrations in healthy adults. Am. J. Clin. Pathol. 134(1), 148-156 (2010).
60. Casetta B, Jans I, Billen J, Vanderschueren D, Bouillon R. Development of a method for the quantification of 1alpha,25(OH)2-vitamin D3 in serum by liquid chromatography tandem mass spectrometry without derivatization. Eur. J. Mass Spectrom. 16(1), 81-89 (2010).
61. Shah I, Petroczi A, Naughton DP. Method for simultaneous analysis of eight analogues of vitamin D using liquid chromatography tandem mass spectrometry. Chem. Cent. J. 6(112), doi:10.1186/1752-153X-6-112 (2012).
62. Baecher S, Leinenbach A, Wright JA, Pongratz S, Kobold U, Thiele R. Simultaneous quantification of four vitamin D metabolites in human serum using high performance liquid chromatography tandem mass spectrometry for vitamin D profiling. Clin. Biochem. 45(16-17), 1491-1496 (2012).
63. Duan X, Weinstock-Guttman B, Wang H et al. Ultrasensitive quantification of serum vitamin D metabolites using selective solid-phase extraction coupled to microflow liquid chromatography and isotope-dilution mass spectrometry. Anal. Chem. 82(6), 2488-2497 (2010).
64. Lenders JW. Biochemical diagnosis of pheochromocytoma and paraganglioma. Ann. Endocrinol. (Paris) 70(3), 161-165 (2009).
65. de Jong WH, de Vries EG, Kema IP. Current status and future developments of LC-MS/MS in clinical chemistry for quantification of biogenic amines. Clin. Biochem. 44(1), 95-103 (2011).
66. Braverman LE, Utiger RD. The Thyroid. Lippincott Williams & Wilkins, PA, USA (2013).
67. Soldin OP, Soldin SJ. Thyroid hormone testing by tandem mass spectrometry. Clin. Biochem. 44(1), 89-94 (2011).
68. Bicker J, Fortuna A, Alves G, Falcao A. Liquid chromatographic methods for the quantification of catecholamines and their metabolites in several biological samples -a review. Anal. Chim. Acta 768, 12-34 (2013).
69. Jonklaas J, Kahric-Janicic N, Soldin OP, Soldin SJ. Correlations of free thyroid hormones measured by tandem mass spectrometry and immunoassay with thyroid-stimulating hormone across 4 patient populations. Clin. Chem. 55(7), 1380-1388 (2009).
70. Eisenhofer G, Lattke P, Herberg M et al. Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma. Ann. Clin. Biochem. 50(Pt 1), 62-69 (2013).
71. Dunand M, Gubian D, Stauffer M, Abid K, Grouzmann E High-throughput and sensitive quantitation of plasma catecholamines by ultraperformance liquid chromatography-tandem mass spectrometry using a solid phase microwell extraction plate. Anal. Chem. 85(7), 3539-3544 (2013).
72. Chirita RI, Finaru AL, Elfakir C. Evaluation of fused-core and monolithic versus porous silica-based C18 columns and porous graphitic carbon for ion-pairing liquid chromatography analysis of catecholamines and related compounds. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(9-10), 633-640 (2011).
73. Yue B, Rockwood AL, Sandrock T, La'ulu SL, Kushnir MM, Meikle AW. Free thyroid hormones in serum by direct equilibrium dialysis and online solid-phase extraction -liquid chromatography/tandem mass spectrometry. Clin. Chem. 54(4), 642-651 (2008).
74. Ackermans MT, Klieverik LP, Endert E, Sauerwein HP, Kalsbeek A, Fliers E. Plasma insulin concentrations during a hyperinsulinaemic clamp: what do we measure? Ann. Clin. Biochem. 45(Pt 4), 429-430 (2008).
75. Vieira JG. PTH assays: understanding what we have and forecasting what we will have. J. Osteoporos. 2012, 523246 (2012) (Epub).
76. van den Broek I, Sparidans RW, Schellens JH, Beijnen JH. Quantitative bioanalysis of peptides by liquid chromatography coupled to (tandem) mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 872(1-2), 1-22 (2008).
77. Bronsema KJ, Bischoff R, van de Merbel NC. Internal standards in the quantitative determination of protein biopharmaceuticals using liquid chromatography coupled to mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 893-894, 1-14 (2012).
78. Pailleux F, Beaudry F. Internal standard strategies for relative and absolute quantitation of peptides in biological matrices by liquid chromatography tandem mass spectrometry. Biomed. Chromatogr. 26(8), 881-891 (2012).
79. Halquist MS, Thomas KH. Quantitative liquid chromatography tandem mass spectrometry analysis of macromolecules using signature peptides in biological fluids. Biomed. Chromatogr. 25(1-2), 47-58 (2011).
80. Barton C, Kay RG, Gentzer W, Vitzthum F, Pleasance S. Development of high-throughput chemical extraction techniques and quantitative HPLC-MS/MS (SRM) assays for clinically relevant plasma proteins. J. Proteome Res. 9(1), 333-340 (2010).
81. Thevis M, Thomas A, Schanzer W. Doping control analysis of selected peptide hormones using LC-MS(/MS). Forensic Sci. Int. 213(1-3), 35-41 (2011).
82. Thomas A, Solymos E, Schanzer W et al. Determination of vasopressin and desmopressin in urine by means of liquid chromatography coupled to quadrupole time-of-flight mass spectrometry for doping control purposes. Anal. Chim. Acta 707(1-2), 107-113 (2011).
83. Thomas A, Schanzer W, Delahaut P, Thevis M. Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls. Methods 56(2), 230-235 (2012).
84. Thomas A, Hoppner S, Geyer H et al. Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry. Anal. Bioanal. Chem. 401(2), 507-516 (2011).
85. Thomas A, Geyer H, Kamber M, Schanzer W, Thevis M. Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS. J. Mass Spectrom. 43(7), 908-915 (2008).
86. Van Eeckhaut A, Maes K, Aourz N, Smolders I, Michotte Y. The absolute quantification of endogenous levels of brain neuropeptides in vivo using LC-MS/MS. Bioanalysis 3(11), 1271-1285 (2011).
87. Lee JI, Kim JY, Choi JY et al. Differences in serum thyroglobulin measurements by 3 commercial immunoradiometric assay kits and laboratory standardization using Certified Reference Material 457 (CRM-457). Head Neck 32(9), 1161-1166 (2010).
88. Rodriguez-Cabaleiro D, Van UK, Stove V, Fiers T, Thienpont LM. Pilot study for the standardization of insulin immunoassays with isotope dilution liquid chromatography/tandem mass spectrometry. Clin. Chem. 53(8), 1462-1469 (2007).
89. Van Uytfanghe K, Rodriguez-Cabaleiro D, Stockl D, Thienpont LM. New liquid chromatography/electrospray ionisation tandem mass spectrometry measurement procedure for quantitative analysis of human insulin in serum. Rapid Commun. Mass Spectrom. 21(5), 819-821 (2007).
90. Hoofnagle AN, Becker JO, Wener MH, Heinecke JW. Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry. Clin. Chem. 54(11), 1796-1804 (2008).
91. Zhang G, Zhang Y, Fast DM, Lin Z, Steenwyk R. Ultra sensitive quantitation of endogenous oxytocin in rat and human plasma using a two-dimensional liquid chromatography-tandem mass spectrometry assay. Anal. Biochem. 416(1), 45-52 (2011).
92. Seger C. Usage and limitations of liquid chromatography-tandem mass spectrometry (LC-MS/MS) in clinical routine laboratories. Wien. Med. Wochenschr. 162(21-22), 499-504 (2012).
93. Higashi T, Nishio T, Uchida S, Shimada K, Fukushi M, Maeda M. Simultaneous determination of 17alpha-hydroxypregnenolone and 17alpha-hydroxyprogesterone in dried blood spots from low birth weight infants using LC-MS/MS. J. Pharm. Biomed. Anal. 48(1), 177-182 (2008).
94. Guo T, Gu J, Soldin OP, Singh RJ, Soldin SJ. Rapid measurement of estrogens and their metabolites in human serum by liquid chromatography-tandem mass spectrometry without derivatization. Clin. Biochem. 41(9), 736-741 (2008).
95. Turpeinen U, Hamalainen E, Stenman UH. Determination of aldosterone in serum by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 862(1-2), 113-118 (2008).
96. Turpeinen U, Linko S, Itkonen O, Hamalainen E. Determination of testosterone in serum by liquid chromatography-tandem mass spectrometry. Scand. J. Clin. Lab. Invest. 68(1), 50-57 (2008).
97. Thienpont LM, Van UK, Blincko S et al. State-of-the-art of serum testosterone measurement by isotope dilution-liquid chromatography-tandem mass spectrometry. Clin. Chem. 54(8), 1290-1297 (2008).
98. Yamashita K, Okuyama M, Nakagawa R et al. Development of sensitive derivatization method for aldosterone in liquid chromatography-electrospray ionization tandem mass spectrometry of corticosteroids. J. Chromatogr. A 1200(2), 114-121 (2008).
99. Carvalho VM, Nakamura OH, Vieira JG. Simultaneous quantitation of seven endogenous C-21 adrenal steroids by liquid chromatography tandem mass spectrometry in human serum. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 872(1-2), 154-161 (2008).
100. Janzen N, Sander S, Terhardt M, Peter M, Sander J. Fast and direct quantification of adrenal steroids by tandem mass spectrometry in serum and dried blood spots. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 861(1), 117-122 (2008).
101. Salameh WA, Redor-Goldman MM, Clarke NJ, Reitz RE, Caulfield MP. Validation of a total testosterone assay using high-turbulence liquid chromatography tandem mass spectrometry: total and free testosterone reference ranges. Steroids 75(2), 169-175 (2010).
102. Ionita IA, Fast DM, Akhlaghi F. Development of a sensitive and selective method for the quantitative analysis of cortisol, cortisone, prednisolone and prednisone in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877(8-9), 765-772 (2009).
103. Perogamvros I, Owen LJ, Newell-Price J, Ray DW, Trainer PJ, Keevil BG. Simultaneous measurement of cortisol and cortisone in human saliva using liquid chromatography-tandem mass spectrometry: application in basal and stimulated conditions. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877(29), 3771-3775 (2009).
104. Shibayama Y, Higashi T, Shimada K et al. Simultaneous determination of salivary testosterone and dehydroepiandrosterone using LC-MS/MS: method development and evaluation of applicability for diagnosis and medication for late-onset hypogonadism. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877(25), 2615-2623 (2009).
105. Taylor PJ, Cooper DP, Gordon RD, Stowasser M. Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry. Clin. Chem. 55(6), 1155-1162 (2009).
106. Yamashita K, Miyashiro Y, Maekubo H et al. Development of highly sensitive quantification method for testosterone and dihydrotestosterone in human serum and prostate tissue by liquid chromatography-electrospray ionization tandem mass spectrometry. Steroids 74(12), 920-926 (2009).
107. Licea-Perez H, Wang S, Szapacs ME, Yang E. Development of a highly sensitive and selective UPLC/MS/MS method for the simultaneous determination of testosterone and 5alpha-dihydrotestosterone in human serum to support testosterone replacement therapy for hypogonadism. Steroids 73(6), 601-610 (2008).
108. Cuzzola A, Petri A, Mazzini F, Salvadori P. Application of hyphenated mass spectrometry techniques for the analysis of urinary free glucocorticoids. Rapid Commun. Mass Spectrom. 23(18), 2975-2982 (2009).
109. Rossi C, Calton L, Hammond G et al. Serum steroid profiling for congenital adrenal hyperplasia using liquid chromatography-tandem mass spectrometry. Clin. Chim. Acta 411(3-4), 222-228 (2010).
110. Janzen N, Sander S, Terhardt M et al. Rapid steroid hormone quantification for congenital adrenal hyperplasia (CAH) in dried blood spots using UPLC liquid chromatography-tandem mass spectrometry. Steroids 76(13), 1437-1442 (2011).
111. Magnisali P, Chalioti MB, Livadara T et al. Simultaneous quantification of 17alpha-OH progesterone, 11-deoxycortisol, Delta4-androstenedione, cortisol and cortisone in newborn blood spots using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(19), 1565-1572 (2011).
112. Jones RL, Owen LJ, Adaway JE, Keevil BG. Simultaneous analysis of cortisol and cortisone in saliva using XLC-MS/MS for fully automated online solid phase extraction. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 881-882, 42-48 (2012).
113. Owen LJ, Adaway JE, Davies S et al. Development of a rapid assay for the analysis of serum cortisol and its implementation into a routine service laboratory. Ann. Clin. Biochem. 50(Pt 4), 345-352 (2013).
114. Buttler RM, Struys EA, Addie R, Blankenstein MA, Heijboer AC. Measurement of dehydroepiandrosterone sulfate (DHEAS) in serum and cerebrospinal fluid by isotope-dilution liquid chromatography tandem mass spectrometry. Clin. Chim. Acta 414, 246-247 (2012).
115. Kulle AE, Welzel M, Holterhus PM, Riepe FG. Implementation of a liquid chromatography tandem mass spectrometry assay for eight adrenal C-21 steroids and pediatric reference data. Horm. Res. Paediatr. 79(1), 22-31 (2013).
116. Hinchliffe E, Carter S, Owen LJ, Keevil BG. Quantitation of aldosterone in human plasma by ultra high performance liquid chromatography tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 913-914, 19-23 (2013).
117. French D. Development and validation of a serum total testosterone liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay calibrated to NIST SRM 971. Clin. Chim. Acta 415, 109-117 (2013).
118. Soeborg T, Frederiksen H, Fruekilde P, Johannsen TH, Juul A, Andersson AM. Serum concentrations of DHEA, DHEAS, 17alpha-hydroxyprogesterone, delta4-androstenedione and testosterone in children determined by TurboFlow-LC-MS/MS. Clin. Chim. Acta 419, 95-101 (2013).
119. Aronov PA, Hall LM, Dettmer K, Stephensen CB, Hammock BD. Metabolic profiling of major vitamin D metabolites using Diels-Alder derivatization and ultra-performance liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 391(5), 1917-1930 (2008).
120. Higashi T, Shibayama Y, Fuji M, Shimada K. Liquid chromatography-tandem mass spectrometric method for the determination of salivary 25-hydroxyvitamin D3: a noninvasive tool for the assessment of vitamin D status. Anal. Bioanal. Chem. 391(1), 229-238 (2008).
121. Newman MS, Brandon TR, Groves MN, Gregory WL, Kapur S, Zava DT. A liquid chromatography/tandem mass spectrometry method for determination of 25-hydroxy vitamin D2 and 25-hydroxy vitamin D3 in dried blood spots: a potential adjunct to diabetes and cardiometabolic risk screening. J. Diabetes Sci. Technol. 3(1), 156-162 (2009).
122. Bunch DR, Miller AY, Wang S. Development and validation of a liquid chromatography-tandem mass spectrometry assay for serum 25-hydroxyvitamin D2/D3 using a turbulent flow online extraction technology. Clin. Chem. Lab. Med. 47(12), 1565-1572 (2009).
123. Ding S, Schoenmakers I, Jones K, Koulman A, Prentice A, Volmer DA. Quantitative determination of vitamin D metabolites in plasma using UHPLC-MS/MS. Anal. Bioanal. Chem. 398(2), 779-789 (2010).
124. van den Ouweland JM, Beijers AM, Demacker PN, van DH. Measurement of 25-OH-vitamin D in human serum using liquid chromatography tandem-mass spectrometry with comparison to radioimmunoassay and automated immunoassay. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 878(15-16), 1163-1168 (2010).
125. Tai SS, Bedner M, Phinney KW. Development of a candidate reference measurement procedure for the determination of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal. Chem. 82(5), 1942-1948 (2010).
126. Wang Z, Senn T, Kalhorn T et al. Simultaneous measurement of plasma vitamin D(3) metabolites, including 4beta,25-dihydroxyvitamin D(3), using liquid chromatography-tandem mass spectrometry. Anal. Biochem. 418(1), 126-133 (2011).
127. Strathmann FG, Laha TJ, Hoofnagle AN. Quantification of 1alpha,25-dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry. Clin. Chem. 57(9), 1279-1285 (2011).
128. Yuan C, Kosewick J, He X, Kozak M, Wang S. Sensitive measurement of serum 1alpha,25-dihydroxyvitamin D by liquid chromatography/tandem mass spectrometry after removing interference with immunoaffinity extraction. Rapid Commun. Mass Spectrom. 25(9), 1241-1249 (2011).
129. Xie W, Chavez-Eng CM, Fang W et al. Quantitative liquid chromatographic and tandem mass spectrometric determination of vitamin D3 in human serum with derivatization: a comparison of in-tube LLE, 96-well plate LLE and in-tip SPME. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(17-18), 1457-1466 (2011).
130. Higashi T, Suzuki M, Hanai J et al. A specific LC/ESI-MS/MS method for determination of 25-hydroxyvitamin D3 in neonatal dried blood spots containing a potential interfering metabolite, 3-epi-25-hydroxyvitamin D3. J. Sep. Sci. 34(7), 725-732 (2011).
131. Adamec J, Jannasch A, Huang J et al. Development and optimization of an LC-MS/MS-based method for simultaneous quantification of vitamin D2, vitamin D3, 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3. J. Sep. Sci. 34(1), 11-20 (2011).
132. Bruce SJ, Rochat B, Beguin A et al. Analysis and quantification of vitamin D metabolites in serum by ultra-performance liquid chromatography coupled to tandem mass spectrometry and high-resolution mass spectrometry -a method comparison and validation. Rapid Commun. Mass Spectrom. 27(1), 200-206 (2013).
133. Bedner M, Phinney KW. Development and comparison of three liquid chromatography-atmospheric pressure chemical ionization/mass spectrometry methods for determining vitamin D metabolites in human serum. J. Chromatogr. A 1240, 132-139 (2012).
134. Thibeault D, Caron N, Djiana R, Kremer R, Blank D. Development and optimization of simplified LC-MS/MS quantification of 25-hydroxyvitamin D using protein precipitation combined with on-line solid phase extraction (SPE). J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 883-884, 120-127 (2012).
135. Gervasoni J, Cocci A, Zuppi C, Persichilli S. Total 25-hydroxyvitamin D determination by an entry level triple quadrupole instrument: comparison between two commercial kits. Biomed. Res. Int. 2013, 270426 (2013).
136. Gu Q, Shi X, Yin P, Gao P, Lu X, Xu G. Analysis of catecholamines and their metabolites in adrenal gland by liquid chromatography tandem mass spectrometry. Anal. Chim. Acta 609(2), 192-200 (2008).
137. Piehl S, Heberer T, Balizs G, Scanlan TS, Kohrle J. Development of a validated liquid chromatography/tandem mass spectrometry method for the distinction of thyronine and thyronamine constitutional isomers and for the identification of new deiodinase substrates. Rapid Commun. Mass Spectrom. 22(20), 3286-3296 (2008).
138. Whiting MJ. Simultaneous measurement of urinary metanephrines and catecholamines by liquid chromatography with tandem mass spectrometric detection. Ann. Clin. Biochem. 46(Pt 2), 129-136 (2009).
139. Monaghan PJ, Brown HA, Houghton LA, Keevil BG. Measurement of serotonin in platelet depleted plasma by liquid chromatography tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877(22), 2163-2167 (2009).
140. de Jong WH, de Vries EG, Wolffenbuttel BH, Kema IP. Automated mass spectrometric analysis of urinary free catecholamines using on-line solid phase extraction. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 878(19), 1506-1512 (2010).
141. Marrington R, Johnston J, Knowles S, Webster C. Measurement of urinary metadrenaline and normetadrenaline by liquid chromatography tandem mass spectrometry for the diagnosis of phaeochromocytoma. Ann. Clin. Biochem. 47(Pt 5), 467-475 (2010).
142. Ackermans MT, Klieverik LP, Ringeling P, Endert E, Kalsbeek A, Fliers E. An online solid-phase extraction-liquid chromatography-tandem mass spectrometry method to study the presence of thyronamines in plasma and tissue and their putative conversion from 13C6-thyroxine. J. Endocrinol. 206(3), 327-334 (2010).
143. Clark ZD, Frank EL. Urinary metanephrines by liquid chromatography tandem mass spectrometry: using multiple quantification methods to minimize interferences in a high throughput method. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(31), 3673-3680 (2011).
144. He X, Gabler J, Yuan C, Wang S, Shi Y, Kozak M. Quantitative measurement of plasma free metanephrines by ion-pairing solid phase extraction and liquid chromatography-tandem mass spectrometry with porous graphitic carbon column. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(23), 2355-2359 (2011).
145. Gabler J, Miller A, Wang S. A simple liquid chromatography-tandem mass spectrometry method for measuring metanephrine and normetanephrine in urine. Clin. Chem. Lab. Med. 49(7), 1213-1216 (2011).
146. Petteys BJ, Graham KS, Parnas ML, Holt C, Frank EL. Performance characteristics of an LC-MS/MS method for the determination of plasma metanephrines. Clin. Chim. Acta 413(19-20), 1459-1465 (2012).
147. Fang L, Lv Y, Sheng X, Yao S. Sensitive, rapid and easy analysis of three catecholamine metabolites in human urine and serum by liquid chromatography tandem mass spectrometry. J. Chromatogr. Sci. 50(5), 450-456 (2012).
148. Peitzsch M, Prejbisz A, Kroiss M et al. Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma. Ann. Clin. Biochem. 50(Pt 2), 147-155 (2013).
149. Gosetti F, Mazzucco E, Gennaro MC, Marengo E. Simultaneous determination of sixteen underivatized biogenic amines in human urine by HPLC-MS/MS. Anal. Bioanal. Chem. 405(2-3), 907-916 (2013).
150. Zhang G, Zhang Y, Ji C et al. Ultra sensitive measurement of endogenous epinephrine and norepinephrine in human plasma by semi-automated SPE-LC-MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 895-896, 186-190 (2012).
151. Cai HL, Zhu RH, Li HD. Determination of dansylated monoamine and amino acid neurotransmitters and their metabolites in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry. Anal. Biochem. 396(1),103-111 (2010).
152. Bredehoft M, Schanzer W, Thevis M. Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry. Rapid Commun. Mass Spectrom. 22(4), 477-485 (2008).
153. Kumar V, Barnidge DR, Chen LS et al. Quantification of serum 1-84 parathyroid hormone in patients with hyperparathyroidism by immunocapture in situ digestion liquid chromatography-tandem mass spectrometry. Clin. Chem. 56(2), 306-313 (2010).
154. Sobhi HR, Vatansever B, Wortmann A, Grouzmann E, Rochat B. Generic approach for the sensitive absolute quantification of large undigested peptides in plasma using a particular liquid chromatography-mass spectrometry setup. J. Chromatogr. A 1218(47), 8536-8543 (2011).
155. Carter S, Owen LJ, Kerstens MN, Dullaart RP, Keevil BG. A liquid chromatography tandem mass spectrometry assay for plasma renin activity using online solid-phase extraction. Ann. Clin. Biochem. 49(Pt 6), 570-579 (2012).
156. Chen Z, Caulfield MP, McPhaul MJ, Reitz RE, Taylor SW, Clarke NJ. Quantitative insulin analysis using liquid chromatography-tandem mass spectrometry in a high-throughput clinical laboratory. Clin. Chem. 59(9), 1349-1356 (2013).